Last updated: February 10, 2023
Sponsor: University Hospital, Caen
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hormone Deficiencies
Diabetes (Pediatric)
Treatment
N/AClinical Study ID
NCT04826627
19-041
Ages < 24 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All children less than 24 months of age
- scheduled for conventional inpatient surgery will be included
Exclusion
Exclusion Criteria:
- Children receiving intravenous fluids during the fasting period
- children managed in ambulatory surgery
- children with an ASA score strictly greater than 3
- children managed in the emergency operating room
- children with an acute metabolic disorder
- an endocrine pathology or a pathology requiring the chronic use of drugs modifyingglycemia (insulin, oral antidiabetics, glucagon, gabapentin, antidepressants andneuroleptics, conversion enzyme inhibitors (CEI)
- beta blockers, statins, anti-transplant treatments, corticoids, antimalarial drugs,the following antibiotics fluoroquinolones, doxycycline, sulfamethoxazole,trimethoprim)
Study Design
Total Participants: 300
Study Start date:
July 15, 2021
Estimated Completion Date:
April 15, 2023
Study Description
Connect with a study center
CHU Caen Normandie
Caen, 14000
FranceActive - Recruiting
Hôpital Necker Enfants Malades
Paris, 75015
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.